Evaluating criteria for breast reduction in public healthcare
Official title: Indications for Breast Reduction in the Public Health Care System
Run by Vastra Gotaland Region · NCT04889469 · Data updated 2026-11-12
This study is trying to figure out the best ways to decide who can get breast reduction surgery in public healthcare by looking at factors like weight, breast size, and symptoms to see how they affect recovery and satisfaction.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 75 Years |
| Sex | Women only |
| Enrollment | 2000 (estimated) |
| Sponsor | Vastra Gotaland Region Government |
| Locations | 1 site (Gothenburg) |
| Status | Recruiting |
| Started | August 1, 2021 |
| Main results expected | August 1, 2028 |
| Study ends | August 1, 2031 |
| Registry record updated | July 3, 2025 |
| Trial ID | NCT04889469 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include women with breast volume greater than 800 ml, specific BMI criteria based on age, and symptoms of breast hypertrophy.
✕Probably not a fit
Patients who do not meet the eligibility criteria, such as those with lower breast volume or higher BMI, may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This project aims to establish a scientific basis for determining which patients should be eligible for breast reduction surgery within the public health care system. It will examine current national guidelines and investigate how factors such as BMI, breast volume, and preoperative symptoms influence surgical outcomes, including complication risks and patient satisfaction. Additionally, the study will assess the economic implications of breast reduction, focusing on maximizing health benefits while minimizing costs. The research will include both operated and non-operated controls to provide a comprehensive analysis of the benefits of breast reduction.
Why it matters
Potential benefit: If successful, this study could lead to improved guidelines for breast reduction surgery, enhancing patient outcomes and satisfaction.
How similar studies have gone: While there have been studies on breast reduction, this specific approach focusing on economic perspectives and detailed patient criteria is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Breast volume \> 800 ml * BMI\< 25 if under 50 years of age and BMI\<2 if over the age of 50 * Symptoms of breast hypertrophy * Non-smokers Un-operad controls: -Symptoms of breast hypertrophy, but do not comply with the criteria above. Augmented controls: * Augmented breast volume \> 800 ml * BMI\< 25 if under 50 years of age and BMI\<2 if over the age of 50 Exclusion Criteria: * Inability to provide informed consent * Inability to understand the Swedish language * Age under 18 years
Where it's running
-
Sahlgrenska university hospital
Gothenburg, Sweden Recruiting
Study contacts
- Principal investigator: Emma Hansson, PhD — Göteborg University
- Study coordinator: Emma Hansson, PhD
- Email: emma.hansson.2@gu.se
- Phone: +46313421000
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Treatment of breast hyperplasia with Xiangjurupining Capsule
This study is testing if a traditional Chinese medicine called Xiangjurupining Capsule can help women aged 18 to 50 with breast hyperplasia feel better and improve their breast health.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.